Department of Biology
The Department of Biology welcomes staff and students from around the world. We celebrate excellence, breadth and diversity across the spectrum of modern biology. We are proud to foster a supportive culture that allows all staff and students to reach their full potential.
The Department of Biology has a research portfolio that spans ecology to structural biology, and the Department’s research has been judged world leading in biochemistry, chronic disease, microbiology, plant biology and ecology. Departmental research is focused around fundamental science research foci, which are Cell and Developmental Biology, Molecular and Cellular Medicine, Bioinformatics and Mathematical Biology, Infection and Immunity, Ecology and Evolution, Microbiology, Biochemistry and Biophysics and Plant Biology.
The health and social care sectors are a major part of society, touching everybody’s lives at some time, employing thousands of people and consuming considerable resources. Investigating the factors that determine our health and wellbeing is key to ensuring the appropriate provision of care. Difficult decisions have to be made on a daily basis, including the choice of treatments provided; the way the health and social care system should be organised, paid for and monitored; how to reward the workforce; the role of patients and the public in the health and social care system. CHE’s research is designed to provide analytical frameworks and evidence to support these sorts of decisions.
CRD is a research department that specialises in evidence synthesis, assembling and analysing data from multiple research studies to generate policy relevant research. We undertake high quality systematic reviews and associated economic evaluations, develop underpinning methods, and promote and facilitate the use of research evidence in decision-making.
Over the past 20 years we have completed over 200 systematic reviews covering a wide range of health care topics, many of which have had a direct impact on national policy. Building on the new University of York Research Strategy CRD is extending into new policy areas aligned with health and wellbeing.
Supported by world-leading facilities, we produce fundamental and applied research of an exceptional standard, with a focus on interdisciplinary, problem-solving research.
We strive for our diverse research community to meets its full potential. We were the first chemistry department in the UK to receive an Athena SWAN Gold award for our gender equality practice, which was recently renewed in recognition of our commitment and achievements. And we provide expertise and advise policymakers as well as collaborating with industrial partners.
Clinical research at York is a joint venture, utilising the expertise and resources of the University, Hull York Medical School and York Teaching Hospital NHS Trust, providing an environment that can deliver early phase trials (phase I and phase II) and support basic scientific research, which will result in high impact results.
Our Immunology, Haematology and Infection theme evolved from the Centre for Immunology and Infection, which was established in 2004.
The Centre established a close working relationship with York Teaching Hospital NHS Foundation Trust in 2009 to support basic and translational research. Jointly, we have successfully delivered several phase I and II trials over these years.
Research has mainly covered sexual health and infectious disease but also clinical trials in oncology, ophthalmology and rheumatology.
Following the University’s acquisition of a Human Tissue Authority research license, the York Tissue Bank was established. This initiative aims to develop networks with the clinical care teams and provide researchers from both the hospital and university with access to human tissue for basic and translational research.
Health Sciences is a large multi-disciplinary and multi-professional department with a strong international reputation for delivering high quality impact-focused research that improves health and healthcare. Our research is strongly collaborative. Please see what we do through our overview of research.
The joint medical school of the Universities of Hull and York, Hull York Medical School has a reputation as one of the UKs most exciting, contemporary schools. Established in 2003 it combines York’s strengths in biological science and health sciences and Hull’s Postgraduate Medical School and large clinical base. Hull York Medical School has recently been allocated 75 additional medical school places as part of HEFCE’s Expansion of Undergraduate Medical Education, which represents a 69% increase in home places to 220 in 2019. Hull York Medical School offers exceptional medical education delivered by senior academics and clinicians in a stimulating and supportive environment with world-class facilities.
We are a community of mathematicians from all over the world, engaged in world-class research and committed to excellence in teaching with a special emphasis on small groups and a friendly atmosphere. You can find out more about the department here.
The York Biomedical Research Institute (YBRI) focuses on answering core questions in the biomedical field around topics such as diabetes, molecular mechanisms, cancer and infectious diseases. Hosting over 80 principal investigators covering a range of disciplines, we provide an environment that allows novel collaborations to flourish.
Our research centres on three themes, Neuroscience, Molecular and Cellular Medicine, and Immunology, Haematology and Infection, with each having a Theme Leader to drive research and innovation forwards.
The Bioscience Technology Facility provides access to technology and research services for the biosciences. This unique facility allows ready access to a wide range of technologies and expertise in an integrated manner that can help drive forward your research efficiently and cost effectively.